Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

French pharma giant Sanofi SNY recently announced that it has agreed to acquire Massachusetts-based biotech Vigil ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...

Know the steps to take to protect yourself on social media. Watch the video. Help Register Login Login Hi, %{firstName}% Hi, ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

EMA’s reluctance in approving drugs for the condition underscores Europe’s prioritisation of long-term safety over rapid ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

The test potentially makes it easier to find and treat patients with the memory-robbing disease. Read more at ...

Eli Lilly (NYSE:LLY) has received regulatory approval to market its Alzheimer’s therapy Kisunla (donanemab) in Australia, ...

U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer’s. The test would help identify ...